Click Therapeutics Announces Participation in Upcoming Investor Conferences in May and June

Click Therapeutics Announces Participation in Upcoming Investor Conferences in May and June

NEW YORK--Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ solutions as prescription medical treatments, today announced that the Company will present at and/or participate in the following virtual investor conferences in May and June:

• RBC 2020 Capital Markets Global Healthcare Conference on May 19-20, 2020
• SVB Leerink CybeRx Series: Digital Health - Innovators & Disruptors on May 21, 2020
• Jefferies 2020 Healthcare Conference on June 2-4, 2020

Investors attending the conferences who would like to schedule one-on-one meetings with Click executives can do so by contacting Ross Muken.

About Click Therapeutics

Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for patients with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Click is progressing a broad pipeline of Digital Therapeutics™ across a variety of high-burden therapeutic areas, including Major Depressive Disorder, Schizophrenia, Migraine, Multiple Sclerosis, Chronic Pain, Atopic Dermatitis, Acute Coronary Syndrome, Obesity, Oncology and more. For more information on Click, visit ClickTherapeutics.com.

Contacts

Company Contact
Jonathan Sirota Senior Associate, Corporate Finance jsirota@clicktherapeutics.com

Media Contact
Karen Sharma
ksharma@macbiocom.com
781-235-3060